Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRAF | P15056 | 12/20 | 0.59 |
| ▸ | CSF1R | P07333 | 2/20 | 0.57 |
| ▸ | RAF1 | P04049 | 2/20 | 0.57 |
| ▸ | LYN | P07948 | 1/20 | 0.57 |
| ▸ | TEK | Q02763 | 2/20 | 0.56 |
| ▸ | HCK | P08631 | 1/20 | 0.49 |
| ▸ | NR2C2 | P49116 | 1/20 | 0.49 |
| ▸ | BTK | Q06187 | 1/20 | 0.49 |
| ▸ | ABL1 | P00519 | 2/20 | 0.48 |
| ▸ | BCR | P11274 | 2/20 | 0.48 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12398541 | 0.91 | BRAF (0.59) | BRAFCSF1RLYNHCKNR2C2 | |
| SCHEMBL12465255 | 0.87 | BRAF (0.67) | BRAFCSF1RRAF1LYNTEK | |
| SCHEMBL12465254 | 0.87 | ABL1 (0.52) | BRAFABL1BCR | |
| SCHEMBL12465258 | 0.87 | ABL1 (0.52) | BRAFABL1BCR | |
| SCHEMBL12465141 | 0.86 | BRAF (0.57) | BRAFCSF1RRAF1LYNTEK | |
| SCHEMBL13960025 | 0.85 | CSF1R (0.56) | BRAFCSF1RRAF1LYNTEK | |
| SCHEMBL12465028 | 0.85 | BRAF (0.64) | BRAFCSF1RRAF1LYNTEK | |
| SCHEMBL12465257 | 0.85 | BRAF (0.57) | BRAFCSF1RRAF1LYNTEK | |
| SCHEMBL12464983 | 0.83 | ABL1 (0.50) | BRAFCSF1RTEKABL1BCR | |
| SCHEMBL12398499 | 0.83 | ABL1 (0.55) | BRAFABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889665-B2 | Chemical compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-11-18 | — | — | US | disclosed |
| US-20110183952-A1 | NEW CHEMICAL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183952-A1 | NEW CHEMICAL COMPOUNDS | MKI67, CCNA1, CCNT1 | BRAF 525/4885CSF1R 594/4885RAF1 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.